The author of this article is Dr R.B Smarta, Chairman and Managing Director, Interlink As the healthcare scenario is experiencing the paradigm shift from cure to care, preventive health has received generous importance and hence the biologics. Growing demand for vaccines, monoclonal antibodies and biosimilars are creating excellent business space […]